Christine Dagousset
About Christine Dagousset
Independent director of Olaplex (OLPX) since 2021; age 60 as of April 23, 2025. Former Chanel executive (Global President of Fragrance & Beauty; Global Long Term Development; Global Open Innovation), now founder of CDAGOUSSET Consulting LLC (January 2024). Marketing degree from Institut Supérieur de Gestion ISG. Tenure on OLPX board since August 2021 (Class III, term expires 2027).
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Chanel | Global Open Innovation Officer | Apr 2023 – Dec 2023 | Built innovation capabilities, minority investments for long-term value drivers |
| Chanel | Global Long Term Development Officer | 2018 – 2023 | Strategic long-term initiatives |
| Chanel | Global President, Fragrances & Beauty | 2014 – 2018 | Led operations and strategic direction; built capabilities across marketing, retail, CRM, digital, operations, R&D |
| Chanel | General Manager, Fragrances & Beauty USA | 2005 – 2014 | U.S. business leadership |
| Chanel | Senior Vice President, Skincare | 1998 – 2005 | Skincare leadership |
| L’Oréal | Product Development/Management; led Biotherm Austria | ~1988 – 1998 | International product leadership |
| CDAGOUSSET Consulting LLC | Founder | Jan 2024 – Present | Consulting to companies/investment firms |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Evolved by Nature | Director | Since 2023 | Sustainable biotech consumer products company (not identified as public) |
| Capsum | Director | Prior service | Prior board service (private) |
| Detox Market | Director | Prior service | Prior board service (private) |
Board Governance
- Class III director; term to 2027; Board comprises 10 directors after 2025 meeting; Lead Director is Tricia Glynn; Executive Chair is John P. Bilbrey .
- Committee assignments: Audit Committee member (appointed Dec 2, 2024); Nominating & Corporate Governance Committee member (current) .
- Independence: Board determined Audit Committee members (including Dagousset) meet SEC Rule 10A-3 and Nasdaq independence requirements .
- Attendance/engagement: Board held 4 meetings in FY2024; no director attended fewer than 75% of Board+committee meetings; non-employee directors meet in executive session periodically; 82% attended the 2024 annual meeting .
- Controlled company: Advent-affiliated funds hold majority voting power; OLPX uses Nasdaq “controlled company” exemptions for majority independence and committee composition (Compensation, Nominating not fully independent) but fully complies with Audit Committee independence requirements .
Fixed Compensation
| Metric (USD) | FY2023 | FY2024 |
|---|---|---|
| Fees earned or paid in cash | $136,157 | $111,192 (prorated with Audit Committee membership starting Dec 2, 2024) |
| Stock awards (grant date fair value RSUs) | $150,000 | $150,000 |
| Total director compensation | $286,157 | $261,192 |
- Director cash retainer policy: $100,000 annual; Audit Committee member $15,000 ($30,000 chair); Compensation Committee member $10,000 ($20,000 chair); Nominating member $10,000 ($15,000 chair); Chair of Board $150,000; Lead Director $120,000. Paid quarterly in arrears .
- Annual director equity: RSUs valued ≈$150,000 (or $250,000 for Chair), vest on first anniversary of grant; granted after annual meeting .
- Change-of-control: Director stock options vest in full upon a change of control; RSU annual director grants vest time-based on first anniversary (no COE acceleration disclosed for standard director RSUs) .
Performance Compensation
- No performance-conditioned director compensation disclosed; director RSUs and legacy stock options for Dagousset are time-based vesting only (not tied to revenue, EBITDA, TSR or ESG metrics) .
Other Directorships & Interlocks
| Category | Details |
|---|---|
| Public company directorships | None indicated for Dagousset in OLPX skill matrix (no checkmark under “Service on Other Public Company Boards”) |
| Significant shareholders with potential affiliation | Mousse Partners beneficially owns 5.7% as of Apr 9, 2025; Dagousset previously served in senior roles at Chanel (Mousse Partners’ founder is affiliated with Chanel’s ownership family), but no related-party transaction with Dagousset is disclosed by OLPX |
| Related-party transactions | OLPX reported $0.3 million payments to Pacvue (Advent affiliate) in 2024; no transactions disclosed involving Dagousset |
Expertise & Qualifications
- Board skills matrix: Retail industry, international markets, strategy, marketing/brand development, senior leadership, finance/accounting; no service on other public company boards box checked for her row .
- Deep beauty sector operating expertise (Chanel; L’Oréal) and global brand-building credentials; current consulting role enhances innovation/strategy perspective .
Equity Ownership
| Ownership Detail | As of Apr 8, 2024 | As of Apr 9, 2025 |
|---|---|---|
| Common shares owned | 14,476 | 68,047 |
| Options exercisable within 60 days | 400,185 | 506,250 |
| Total beneficial shares | 414,661 | 574,297 |
| Ownership % of outstanding | <1% (indicated by asterisk) | <1% (indicated by asterisk) |
| Unvested Equity | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|
| RSUs outstanding (#) | 53,571 (eligible to vest Aug 9, 2024) | 76,142 (eligible to vest Jul 16, 2025) |
| Stock options – vested | 342,270 (as of Dec 31, 2023) | 448,335 (as of Dec 31, 2024) |
| Stock options – scheduled vesting | 115,830 (May 1, 2024; plus 48,150 on Oct 4, 2024) | 57,915 (May 1, 2025) |
- Ownership guidelines: Outside directors must hold vested equity equal to 5x annual cash retainer; retain 67% of net shares until compliant; covered incumbents have achieved or are expected to achieve within required timeframe .
- Hedging/pledging: Policy prohibits hedging and pledging/margin accounts for all directors/officers/employees .
Fixed Compensation (Director Program Details)
| Element | Amount/Terms |
|---|---|
| Base cash retainer | $100,000 per year for directors |
| Committee retainers | Audit $15,000 (chair $30,000); Compensation $10,000 (chair $20,000); Nominating $10,000 (chair $15,000) |
| Chair/Lead Director retainers | Chair $150,000; Lead Director $120,000 |
| Equity grant | Annual RSUs ≈$150,000 (≈$250,000 for Chair); vest at 1 year |
Performance Compensation (Director Program)
- Not applicable: OLPX director compensation uses time-based RSUs and legacy stock options; no disclosed performance metrics or PSU structures for non-employee directors .
Potential Conflicts or Related-Party Exposure
- Controlled company: Advent-affiliated funds own 75.0% of common stock (as of Apr 9, 2025), enabling governance exemptions; Dagousset is not listed as Advent-affiliated and is independent on Audit .
- RPTs: Only disclosed related-party transaction in 2024 is $0.3 million to Pacvue (Advent affiliate); none disclosed involving Dagousset or Chanel/Mousse connections .
- Registration Rights & Tax Receivable Agreements: Legacy arrangements benefiting pre-IPO holders; not director-specific and no Dagousset-specific exposure disclosed .
Say-on-Pay & Shareholder Feedback
- 2023 say-on-pay support: Over 91% of votes cast supported NEO compensation (advisory) .
- 2025 annual meeting includes advisory say-on-pay; OLPX states continued consideration of shareholder views in pay decisions .
Compensation Structure Analysis (Director)
- Mix stability: Cash retainer plus time-based RSUs annually; no shift toward guaranteed/performance pay disclosed for directors .
- Options: Legacy option awards continue with time-based vesting and change-of-control acceleration; no repricing policy without shareholder consent reinforces pay discipline .
RED FLAGS
- Controlled company governance exemptions (Board majority independence not required; Compensation/Nominating not fully independent), though Audit Committee remains fully independent -.
- Change-of-control single-trigger vesting for director stock options (alignment consideration; common but can be investor-sensitive) .
Governance Assessment
- Strengths: Independent Audit Committee membership; robust anti-hedging/anti-pledging policy; director ownership guidelines (5x retainer) with compliance trajectory; regular executive sessions; strong industry/brand-building expertise relevant to OLPX’s category - .
- Considerations: Controlled company status and committee composition reduce formal independence in Compensation/Nominating; director option acceleration on change-of-control warrants monitoring; no performance-linked equity for directors (typical, but limits pay-for-performance optics) - .
Additional context
- Committee meetings in FY2024: Audit (5), Compensation (4), Nominating (4) .
- Dagousset’s 2024 RSUs: 76,142 eligible to vest July 16, 2025; options: 506,250, with 57,915 scheduled to vest May 1, 2025; options fully vest on change-of-control -.
- Beneficial ownership as of Apr 9, 2025: 574,297 total (68,047 common; 506,250 options exercisable within 60 days); less than 1% ownership -.